You can buy or sell Neurocrine and other stocks, options, ETFs, and crypto commission-free!
Neurocrine Biosciences, Inc. operates as a product based bio-pharmaceutical company. It discovers, develops and intends to commercialize drugs for the treatment of neurological and endocrine related diseases and disorders. Read More The company product includes INGREZZA. Neurocrine Biosciences was founded by Kevin C. Gorman and Wylie W. Vale on January 1992 and is headquartered in San Diego, CA.
San Diego, California
52 Week High
52 Week Low
Neurocrine Biosciences: Rapid Pipeline Expansion Underway
Since my earlier article, Neurocrine Biosciences (NBIX) shares have retreated quite a bit off all time highs in September 2018. The safety scare was the first major selloff on elevated volume as an increase in reported deaths caused a panic, sending shares down over 10% one day in November.
Yahoo FinanceMar 15
CTLT or NBIX: Which Is the Better Value Stock Right Now?
CTLT vs. NBIX: Which Stock Is the Better Value Option? Investors interested in stocks from the Medical - Drugs sector have probably already heard of Catalent (CTLT) and Neurocrine Biosciences (NBIX). But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look. There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores syst...
Expected Apr 29, After Hours